Viewing Study NCT02383368

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2026-02-19 @ 11:48 AM
Study NCT ID: NCT02383368
Status: COMPLETED
Last Update Posted: 2024-10-31
First Post: 2015-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma
Sponsor: Astellas Pharma Global Development, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Refractory Solid Tumors View
None Advanced Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmacokinetics View
None ASP4132 View
None Lymphoma View
None Refractory Solid Tumors View